Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 10 of 10 entries
Sorted by: Best Match Show Resources per page
Efficacy of 3 Major Ketogenic Diet Therapies in Children With Drug-Resistant Epilepsy-Reply.

JAMA pediatrics

Sondhi V, Gulati S.
PMID: 33492336
JAMA Pediatr. 2021 Apr 01;175(4):434-435. doi: 10.1001/jamapediatrics.2020.5451.

No abstract available.

A randomized controlled trial of the ketogenic diet in refractory childhood epilepsy.

Acta neurologica Scandinavica

Padmanabha H, Suthar R, Sankhyan N.
PMID: 29205271
Acta Neurol Scand. 2018 Jan;137(1):151. doi: 10.1111/ane.12801.

No abstract available.

Use of ketogenic diet therapy in infants with epilepsy: A systematic review and meta-analysis.

Epilepsia

Lyons L, Schoeler NE, Langan D, Cross JH.
PMID: 32452537
Epilepsia. 2020 Jun;61(6):1261-1281. doi: 10.1111/epi.16543. Epub 2020 May 26.

OBJECTIVE: Ketogenic diet therapy (KDT) is a group of high-fat, low-carbohydrate diets used as an effective treatment option for children and adults with drug-resistant epilepsy. There is limited research on the efficacy of KDT in infants, where there is...

To treat or not to treat drug-refractory epilepsy by the ketogenic diet? That is the question.

Annals of agricultural and environmental medicine : AAEM

Ułamek-Kozioł M, Pluta R, Bogucka-Kocka A, Czuczwar SJ.
PMID: 28030918
Ann Agric Environ Med. 2016 Dec 23;23(4):533-536. doi: 10.5604/12321966.1226841.

Epilepsy is a serious neurologic disorder worldwide which affects about 1% of the population (ca. 50 million people), the highest prevalence occurring in both children and elderly. Apart from idiopathic forms, etiology of the disease involves multiple brain risk...

A randomized controlled trial of the ketogenic diet in refractory childhood epilepsy.

Acta neurologica Scandinavica

Lambrechts DAJE, de Kinderen RJA, Vles JSH, de Louw AJA, Aldenkamp AP, Majoie HJM.
PMID: 29205273
Acta Neurol Scand. 2018 Jan;137(1):152-154. doi: 10.1111/ane.12802.

No abstract available.

Cognitive benefits of the ketogenic diet in patients with epilepsy: A systematic overview.

Epilepsy & behavior : E&B

van Berkel AA, IJff DM, Verkuyl JM.
PMID: 30173019
Epilepsy Behav. 2018 Oct;87:69-77. doi: 10.1016/j.yebeh.2018.06.004. Epub 2018 Aug 31.

The ketogenic diet (KD) has been found to be effective in reducing seizures in patients with treatment-refractory epilepsy. Less attention has been paid to additional cognitive benefits of KD. The aim of the present paper was to provide a...

What are the effects of ketogenic diets on drug-resistant epilepsy? A Cochrane Review summary with commentary.

Developmental medicine and child neurology

Arman S.
PMID: 32808681
Dev Med Child Neurol. 2020 Oct;62(10):1121-1123. doi: 10.1111/dmcn.14643. Epub 2020 Aug 18.

No abstract available.

The ketogenic diet in pharmacoresistant childhood epilepsy.

Expert review of neurotherapeutics

Winesett SP, Bessone SK, Kossoff EH.
PMID: 25994046
Expert Rev Neurother. 2015 Jun;15(6):621-8. doi: 10.1586/14737175.2015.1044982. Epub 2015 May 20.

Available pharmacologic treatments for seizures are limited in their efficacy. For a patient with seizures, pharmacologic treatment with available anticonvulsant medications leads to seizure control in

[Multidisciplinary teamwork in the clinical application of the ketogenic diet].

Medicina

Fasulo L, Semprino M, Caraballo R.
PMID: 31284260
Medicina (B Aires). 2019;79(3):225-231.

The ketogenic diet is an established, effective and well-tolerated treatment in refractory epilepsy. This paper provides practical information on the administration of ketogenic diet. It goes over the standardized protocols and the new ones that allow to broaden the...

The ketogenic diet in children 3 years of age or younger: a 10-year single-center experience.

Scientific reports

Kim SH, Shaw A, Blackford R, Lowman W, Laux LC, Millichap JJ, Nordli DR.
PMID: 31217425
Sci Rep. 2019 Jun 19;9(1):8736. doi: 10.1038/s41598-019-45147-6.

The ketogenic diet (KD) is an effective treatment option for intractable epilepsy. Here, we reviewed the last 10 years of our experience with the KD and characterized its use in patients under 3 years of age. Medical records of...

Showing 1 to 10 of 10 entries